ABRYSVO

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Romania, United States

Active ingredients

The drug ABRYSVO contains one active pharmaceutical ingredient (API):

1 RSV glycoprotein F antigen

RSV glycoprotein F antigen is designed to enhance antigen-specific cellular immune response and neutralizing antibodies response in individuals with pre-existing immunity against RSV. The adjuvant AS01E facilitates the recruitment and activation of antigen presenting cells carrying vaccine-derived antigens in the draining lymph node, which in turn leads to the generation of RSVPreF3-specific CD4+ T cells.

Read about RSV glycoprotein F antigen

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ABRYSVO Powder and solvent for solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07BX05 J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BX Other viral vaccines
Discover more medicines within J07BX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 3044618, 3044629, 3044630
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1231752001
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 587002
Country: FR Base de données publique des médicaments Identifier(s): 60990140
Country: IT Agenzia del Farmaco Identifier(s): 050831015, 050831027, 050831039, 050831041, 050831054, 050831066
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1097701, 1097702, 1097703, 1097704, 1097705, 1097706
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W69758001, W69758002, W69758003, W69758004, W69758005, W69758006
Country: US FDA, National Drug Code Identifier(s): 0069-0207, 0069-0250, 0069-0344

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.